XRAY
23
3
ZION
67
-4
XRX
37
3
GD
46
-13
ETN
79
-5
IPG
44
-3
NDAQ
59
-4
CSX
62
-6
SE
57
-3
IRM
39
-3
FAST
61
-3
APD
54
2
ORCL
68
-3
AAP
44
2
AIZ
80
2
DRI
54
-2
AVY
51
-2
OMC
68
4
GWW
69
-9
HRL
39
9
XRAY
23
3
ZION
67
-4
XRX
37
3
GD
46
-13
ETN
79
-5
IPG
44
-3
NDAQ
59
-4
CSX
62
-6
SE
57
-3
IRM
39
-3
FAST
61
-3
APD
54
2
ORCL
68
-3
AAP
44
2
AIZ
80
2
DRI
54
-2
AVY
51
-2
OMC
68
4
GWW
69
-9
HRL
39
9
Financhill
Back

Seelos Therapeutics 10K Form

Sell
8

SEEL
Seelos Therapeutics

Last Price:
0.54
Seasonality Move:
27.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SEEL News And Ratings

See the #1 stock for the next 7 days that we like better than SEEL

SEEL Financial Statistics

Sales & Book Value

Annual Sales: $4.84M
Cash Flow: $-972K
Price / Cash Flow: 0
Annual Sales: $-135.52
Price / Book: 0

Profitability

EPS (TTM): -475.52000
Net Income (TTM): $4.09M
Gross Margin: $3.92M
Return on Equity: 0%
Return on Assets: 0%

Seelos Therapeutics Earnings Forecast

Key Seelos Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 17 years for SEEL is 80.95%.
  • The Selling, General & Administrative Expenses for SEEL have been equal to 217.32% of Gross Profit Margin.
  • The Interest Expense is -0.20% of Operating Income.
  • Per Share Earnings over the last 27 years have been positive in 16 years.

Seelos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SEEL
CUSIP: 81577F
Website: seelostherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SEEL Technical Analysis vs Fundamental Analysis

Sell
8
Seelos Therapeutics (SEEL) is a Sell

Is Seelos Therapeutics a Buy or a Sell?